The Centers for Medicare & Medicaid Services today issued a proposed rule that would revise regulations setting forth the appeals process that Medicare beneficiaries, providers and suppliers must follow in order to appeal adverse determinations regarding claims for benefits under Medicare Parts A and B and prescription drug coverage under Part D. The agency said the changes are intended to streamline and clarify the appeals process and reduce administrative burdens. 

Related News Articles

Perspective
Two weeks ago, I wrote about the
Headline
The U.S. Court of Appeals for the District of Columbia Circuit reversed the voiding of a rule that included Medicare and private insurance payments when…
Headline
The AHA today proposed additional actions that the Centers for Medicare…
Headline
The AHA today voiced support for the Improving Seniors’ Timely Access to Care Act (H.R. 3107), bipartisan legislation that would establish requirements for the…
Headline
Medicare will cover nationally Chimeric Antigen Receptor T-cell therapies approved by the Food and Drug Administration to treat certain cancers, as well as off…
Headline
Offering a government insurance program reimbursing at Medicare rates as a public option on the health insurance exchanges could place as many as 55% of rural…